CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
37 hedge funds and large institutions have $17.3M invested in Carisma Therapeutics in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
47% less funds holding
Funds holding: 70 → 37 (-33)
79% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 42
Holders
37
Holding in Top 10
1
Calls
$2.69M
Puts
$1.57M
Top Buyers
| 1 | +$6.77M | |
| 2 | +$5.22M | |
| 3 | +$159K | |
| 4 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$145K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$101K |
Top Sellers
| 1 | -$361K | |
| 2 | -$265K | |
| 3 | -$174K | |
| 4 |
Bank of New York Mellon
New York
|
-$74.5K |
| 5 |
Morgan Stanley
New York
|
-$65.7K |